Position in AMLX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$17,508,862
-$11,995,236 QoQ
Shares Held
974,881
-54.1% QoQ
Ownership
0.875%
of shares outstanding
% of Portfolio
4.31%
of 13F equity value
Holder Rank
#23
of 207 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Almitas Capital LLC holds $17,990,028 across 2 Drug Manufacturers - Specialty & Generic names. AMLX ranks #1 (97.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
974,881 | $17,508,862 | |
| 2 | TLPH |
Talphera, Inc.
|
467,152 | $481,166 |
All Filings in AMLX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,508,862 | 974,881 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $29,504,098 | 2,122,597 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,640,971 | 2,122,597 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $28,846,093 | 2,122,597 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,605,846 | 2,122,597 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,513,993 | 2,122,597 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,682,358 | 2,032,370 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,442,944 | 1,988,563 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,617,316 | 1,903,851 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||